Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Series/ Type

Series/type

Search tool

Displaying 1 - 6 of 6

Publications

EU Drug Markets Report 2019

27.11.2019

The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis presented in this report spans numerous topics such as the links between drugs and other crimes, the licit economy and society more generally as...

Publications

EMCDDA pilot study of drug-related homicide in Finland, the Netherlands and Sweden

26.11.2019

This paper is part of the EMCDDA activity around the development and improvement of drug supply indicators, with a focus on drug-related homicide. It builds upon the 2017 review of the academic research and data sources on drug-related homicide at national and European/international levels by...

Publications

Methamphetamine in Europe: EMCDDA-Europol threat assessment

26.11.2019

This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution. This is a supporting publication to the 2019 EU Drug Markets Report.

Publications

Highlights from the EU Drug Markets Report for policy and practice

26.11.2019

This short publication presents the main highlights from the EU Drug Markets Report 2019, targeting policy and practice.

Publications

Drug precursor developments in the European Union

26.11.2019

This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU. This includes describing the ‘pre-precursor’ phenomenon and responses to it, both by the EU and by the drug...

Publications

Using open-source information to improve the European drug monitoring system

26.11.2019

This paper explains the methodology developed by the EMCDDA for open-source information monitoring in the area of drug markets. Initially designed to support the work of the EU Early Warning System in 2016, the technique has recently been expanded to cover open-source information through a pilot...
Loading